FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
Day 3 at ISHAM —- FACIS Received High Recognition
New Delhi, India – September 22, 2022 – Genobio with Indian local Partner Bio-State is participating 21th congress of the International Socie...
IGL-200 Successfully Approved by Health Canada
May 15th, 2023 – Era Biology’s Fully Automatic Kinetic Tube Reader (IGL-200), along with its adaptation reagents Fungus (1-3)-β-D-Glucan Detection Kit...
Meet Genobio at ISHAM 2022
The 21st Congress of the International Society for Human and Animal Mycology (ISHAM) will be held in New Delhi, India on 20-24 September 2022.
ISHAM is a worldwide o...
Era Biology will host a global live webinar on November 29th 2022 22:00 (GMT +08:00). The webinar will be in Spanish. The webinar will talk about complete solutions for aspergillus galactomannan te...